Laboratories should expect some false positive results when screening large populations with a low prevalence of COVID-19 infection.

http://www.fda.gov/medical-devices/letters-health-care-providers/potential-false-positive-results-antigen-tests-rapid-detection-sars-cov-2-letter-clinical-laboratory